Our professionals

José Luis Lanciego. Programa Neurociencias. Cima

Dr. José Luis Lanciego Pérez

Principal investigator of the Gene Therapy in Parkinson's Disease group.
Preferential dedication to the development of gene therapy techniques for the treatment of Parkinson's disease and other neurodegenerative processes.

Be part of: Cima Universidad de Navarra

INDEX H 48 (ISI Web of Science, Dec 2023)

Professional career

Degree in Medicine and Surgery from the University of Salamanca in June 1990.

Degree in Medicine and Surgery from the University of Salamanca in September 1990.

Doctor in Medicine and Surgery by the University of Salamanca in October 1994.

He has made research stays at the Vrije Universiteit Amsterdam (The Netherlands).

Since 1997 he is part of the Cima University of Navarra.

Professor of Neurosciences at the University of Navarra.

Principal Investigator of the Parkinson's Disease Group within the Neurosciences Program.

M index: 1.84 (ISI Web of Science, Dec 2023)

RESEARCH AREAS

He is co-inventor of 2 patents to Handl Therapeutics B.V. (Belgium).
He is co-founder and consultant of Handl Therapeutics B.V.
He has participated in more than 20 research projects, being a principal investigator in 18 of them, highlighting competitive projects funded by the European Union (H2020, ERC Advanced, JPND, COEN-Pathfinder, Eranet-Neuron, etc).
He has participated as CRO in several contracts with pharmaceutical companies.

AREAS OF INTEREST

Study of the neurobiology of Parkinson's disease.
Study of G protein-coupled receptors (GPCRs) in the context of Parkinson's disease.
Studies of brain circuits underlying the pathophysiology of Parkinson's disease.
Gene therapy in Parkinson's disease and associated synucleinopathies.

Activity

As an educator

He is Associate Professor of Neurosciences at the Faculty of Medicine.
He has supervised 9 Doctoral Theses, 4 of which were awarded the Extraordinary Doctoral Prize (Universities of Salamanca and Navarra).
He has written 3 books and 10 book chapters.
Invited speaker in more than 15 international courses and seminars.

As a researcher

He has participated in the publication of 120 scientific articles in international journals and in more than 110 communications presented at national/international congresses.

Imagen de un icono azul con un documento certificado.

Scientific organizations

Member of the Centro de Investigación Biomédica en Red de Enfermedades
Neurodegenerativas (CiberNed) as principal investigator since its incorporation in 2006.
He works as CRO for biotechnology and pharmaceutical companies.
Member of the Pan-European Committee of the International Brain Research Organization (IBRO-PERC).
Member of the Higher Education and Training Committee of the Federation of European Neuroscience Societies (CHET-FENS).
Member of the Steering Committee of the International Basal Organization (IBAGS).
Member of the Instituto de Investigaciones Sanitarias de Navarra (IdiSNA) as principal investigator of consolidated group since its constitution in 2015.
Associate Editor of Frontiers in Neuroanatomy.
Associate Editor of Frontiers in Molecular Neuroscience.
Board Member of Brain Structure and Function.
Board Member of the International Journal of Medical Sciences (section of Molecular Neurobiology).
Member of the Society for Neuroscience (SfN; USA), International Basal Organization (IBAGS; USA), Sociedad Española de Neurociencias (SENC; Spain).
Co-founder of Handl Therapeutics B.V. (Lovaina, Bélgica)
Chair of the Pan-European Committee of the International Brain Research Organization (IBRO-PERC) since November 2022.
Board Member of the European Brain Council (Brussels, Belgium), as of November 2023.